Clinical trials: Reduction of Dietary Fumonisin Bioavailability
Reduction of Dietary Fumonisin Bioavailability
G-PUR® for Reduced Dietary Fumonisin Bioavailability
This prospective, placebo-controlled, randomized, monocentric, double-blind, crossover study in healthy volunteers aims to assess the effect of a single dose of 2 g G-PUR® on bioavailability of dietary fumonisin and to evaluate…
- Trial name
- NCT04494178
- Testing
- 2.0g G-PUR®
- Where
- Austria
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- Glock Health, Science and Research GmbH